Evaluating Diastolic Dysfunction as an Indicator of Cirrhotic Cardiomyopathy in Decompensated Chronic Liver Disease

Prashant Kumar1, Amish Shikoh2, Neha Rani3

  • 1Department of Cardiology, Rajendra Institute of Medical Sciences, Ranchi, IND.

Cureus
|July 29, 2024
PubMed

Insights

Left ventricular diastolic dysfunction (LVDD) is a frequent complication in decompensated chronic liver disease (DCLD). Early detection of LVDD through serum bilirubin and QTc interval monitoring can improve survival rates in cirrhotic cardiomyopathy patients.

Area of Science:

  • Cardiology
  • Hepatology
  • Internal Medicine

Background:

  • Cirrhotic cardiomyopathy (CCM) is a common complication in decompensated chronic liver disease (DCLD) patients.
  • The compromised life expectancy in DCLD necessitates understanding CCM's early indicators.

Purpose of the Study:

  • To determine the prevalence of diastolic dysfunction in chronic liver disease patients.
  • To establish diagnostic criteria for left ventricular diastolic dysfunction (LVDD) in cirrhotic patients.
  • To evaluate LVDD as an early indicator of CCM.

Main Methods:

  • A 18-month hospital-based, cross-sectional study of 158 DCLD patients.
  • Clinical and radiological diagnosis of chronic liver disease.
  • Regression analysis to identify predictors of diastolic dysfunction (DD).

Main Results:

  • Age (31-60 years) and elevated serum bilirubin (>2mg/dL) are significant factors for LVDD (p<0.0001).
  • Child-Turcotte-Pugh score (p=0.0180) and prolonged QTc interval (p<0.0001) correlate significantly with LVDD.
  • ROC analysis showed an AUC of 0.64 for predicting LVDD.

Conclusions:

  • LVDD serves as an early indicator of liver cirrhosis severity in DCLD.
  • Prolonged QTc in DCLD patients may increase the risk of ventricular arrhythmias.
  • Regular monitoring of serum bilirubin and ECG (QTc interval) is recommended for early detection and improved survival in DCLD patients.
Abstract